UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Circadian clock gene disruption in white blood cells of patients with celiac disease

Biochimie, 2024-04, Vol.219, p.51-54

2024

Volltextzugriff (PDF)

Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission

Digestive diseases and sciences, 2023-06, Vol.68 (6), p.2454-2462

2023

Volltextzugriff (PDF)

P222 Heart rate variability is a predictor to disease exacerbation in paediatric Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S275-S276

2021

Volltextzugriff (PDF)

P197 The effect of a positive family history on the phenotype and course of paediatric Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S262-S263

2021

Volltextzugriff (PDF)

P122 Longitudinal follow-up of body mass index as a predictor for severe disease course in children with inflammatory bowel disease

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S148-S149

2019

Volltextzugriff (PDF)

P159 Body mass index in the lower or upper quartile is a marker of severe disease course in children with inflammatory bowel disease

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S177-S177

2018

Volltextzugriff (PDF)

P679 Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBD

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S454-S455

2018

Volltextzugriff (PDF)

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN

Journal of pediatric gastroenterology and nutrition, 2022-12, Vol.75 (6), p.717-723

2022

Volltextzugriff (PDF)

P553 The safety and efficacy of adalimumab 80mg weekly as maintenance therapy in pediatric Crohn’s Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1088-i1088

2024

Volltextzugriff (PDF)

PC.01.3 LONG-TERM OUTCOME OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM THE PEDIATRIC IBD PORTO GROUP OF ESPGHAN

Digestive and liver disease, 2023-03, Vol.55, p.S78-S79

2023

Volltextzugriff (PDF)

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed‐up Study)

Journal of pediatric gastroenterology and nutrition, 2022-12, Vol.75 (6), p.717-723

2022

Volltextzugriff (PDF)

P144 Clock gene expression levels inversely correlate with disease activity in ulcerative colitis and Crohn’s disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S228-S228

2021

Volltextzugriff (PDF)

P123 Sarcopenia is a predictor for severe disease course in paediatric inflammatory bowel disease

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S197-S198

2020

Volltextzugriff (PDF)

P210 Long-term outcome of very early onset inflammatory bowel disease associated with primary sclerosing cholangitis: a multicenter study from the Pediatric IBD Porto Group of ESPGHAN

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i361-i362

2023

Volltextzugriff (PDF)

P383 Chronic Recurrent Multifocal Osteomyelitis associated with Paediatric Inflammatory Bowel disease: A Multi-Center Retrospective Study from the Paediatric IBD Porto Group of ESPGHAN

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i805-i805

2024

Volltextzugriff (PDF)

P124 Clock gene expression levels can differentially distinguish between ulcerative colitis and Crohn’s disease

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S198-S200

2020

Volltextzugriff (PDF)

P534 Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i662-i664

2023

Volltextzugriff (PDF)

DOP69 Long-term outcome of infantile and very early onset IBD: A multi-center study from the IBD Porto group of ESPGHAN

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i112-i113

2022

Volltextzugriff (PDF)

OP05 Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i005-i006

2022

Volltextzugriff (PDF)

P150 Identification of features associated with poor outcomes in pediatric patients with ulcerative proctitis: A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i309-i311

2023

Volltextzugriff (PDF)

P323 The interrelationship between hepcidin, vitamin D, and anaemia in children with inflammatory bowel disease (IBD)

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S264-S264

2018

Volltextzugriff (PDF)

P458 Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn’s disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i435-i435

2022

Volltextzugriff (PDF)

Chronic Recurrent Multifocal Osteomyelitis associated with Paediatric Inflammatory Bowel disease: A Multi-Center Retrospective Study from the Paediatric IBD Porto Group of ESPGHAN

JOURNAL OF CROHNS & COLITIS, 2024, Vol.18, p.I797

2024

Volltextzugriff (PDF)

P538 Vedolizumab is effective in real life paediatric inflammatory bowel disease: report from the prospective, multi-centre VEDOKIDS cohort study

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S383-S383

2019

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(89)
Tagungsberichte
(2)

Sprache

Englisch
(91)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Circadian clock gene disruption in white blood cells of patients with celiac disease

Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission

P222 Heart rate variability is a predictor to disease exacerbation in paediatric Inflammatory Bowel Disease

P197 The effect of a positive family history on the phenotype and course of paediatric Inflammatory Bowel Disease

P122 Longitudinal follow-up of body mass index as a predictor for severe disease course in children with inflammatory bowel disease

P159 Body mass index in the lower or upper quartile is a marker of severe disease course in children with inflammatory bowel disease

P679 Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBD

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN

P553 The safety and efficacy of adalimumab 80mg weekly as maintenance therapy in pediatric Crohn’s Disease

PC.01.3 LONG-TERM OUTCOME OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM THE PEDIATRIC IBD PORTO GROUP OF ESPGHAN

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed‐up Study)

P144 Clock gene expression levels inversely correlate with disease activity in ulcerative colitis and Crohn’s disease

Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN

P123 Sarcopenia is a predictor for severe disease course in paediatric inflammatory bowel disease

P210 Long-term outcome of very early onset inflammatory bowel disease associated with primary sclerosing cholangitis: a multicenter study from the Pediatric IBD Porto Group of ESPGHAN

P383 Chronic Recurrent Multifocal Osteomyelitis associated with Paediatric Inflammatory Bowel disease: A Multi-Center Retrospective Study from the Paediatric IBD Porto Group of ESPGHAN

P124 Clock gene expression levels can differentially distinguish between ulcerative colitis and Crohn’s disease

P534 Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN

DOP69 Long-term outcome of infantile and very early onset IBD: A multi-center study from the IBD Porto group of ESPGHAN

OP05 Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study

P150 Identification of features associated with poor outcomes in pediatric patients with ulcerative proctitis: A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN

P323 The interrelationship between hepcidin, vitamin D, and anaemia in children with inflammatory bowel disease (IBD)

P458 Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn’s disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN

Chronic Recurrent Multifocal Osteomyelitis associated with Paediatric Inflammatory Bowel disease: A Multi-Center Retrospective Study from the Paediatric IBD Porto Group of ESPGHAN

P538 Vedolizumab is effective in real life paediatric inflammatory bowel disease: report from the prospective, multi-centre VEDOKIDS cohort study

Suchergebnisse filtern